Magaly Woolard

Magaly Woolard is an experienced professional in the clinical research and operations field, currently serving as Senior Director of Study Start Up at Eikon Therapeutics since March 2024, where responsibilities include managing study and site start-up processes, project and risk management, and analytics. Previously, Magaly held the position of Director of Study Start Up at Regeneron Pharmaceuticals, overseeing the development of the integrated Study Start-Up team. Magaly's extensive background includes strategic roles at Medidata Solutions, Celgene, and Merck, with a focus on optimizing processes, enhancing operational efficiencies, and leading cross-functional teams. Magaly holds a Bachelor of Arts degree in Biology and Psychology from Rutgers University.